These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1536391

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Changes of ultrasonography and two serum biochemical indices for hepatic fibrosis in schistosomiasis japonica patients one year after praziquantel treatment.
    Cai W, Chen Z, Chen F, Zhou C, Liu R, Wang J.
    Chin Med J (Engl); 1997 Oct; 110(10):797-800. PubMed ID: 9642313
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Five-year impact of repeated praziquantel treatment on subclinical morbidity due to Schistosoma japonicum in China.
    Li YS, Sleigh AC, Li Y, Tanner M, Dessein A, Williams GM, McManus DP.
    Trans R Soc Trop Med Hyg; 2002 Oct; 96(4):438-43. PubMed ID: 12497984
    [Abstract] [Full Text] [Related]

  • 8. Two-year impact of praziquantel treatment for Schistosoma japonicum infection in China: re-infection, subclinical disease and fibrosis marker measurements.
    Li YS, Sleigh AC, Ross AG, Li Y, Williams GM, Tanner M, McManus DP.
    Trans R Soc Trop Med Hyg; 2000 Oct; 94(2):191-7. PubMed ID: 10897367
    [Abstract] [Full Text] [Related]

  • 9. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
    Boisier P, Ramarokoto CE, Ravaoalimalala VE, Rabarijaona L, Serieye J, Roux J, Esterre P.
    Trans R Soc Trop Med Hyg; 1998 Oct; 92(4):451-3. PubMed ID: 9850407
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver morbidity due to Schistosoma mekongi in Cambodia after seven rounds of mass drug administration.
    Keang H, Odermatt P, Odermatt-Biays S, Cheam S, Degrémont A, Hatz C.
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):759-65. PubMed ID: 17568642
    [Abstract] [Full Text] [Related]

  • 16. Praziquantel pharmacokinetics and side effects in Schistosoma japonicum-infected patients with liver disease.
    Watt G, White NJ, Padre L, Ritter W, Fernando MT, Ranoa CP, Laughlin LW.
    J Infect Dis; 1988 Mar; 157(3):530-5. PubMed ID: 3125260
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Praziquantel in treatment of cerebral schistosomiasis.
    Watt G, Adapon B, Long GW, Fernando MT, Ranoa CP, Cross JH.
    Lancet; 1986 Sep 06; 2(8506):529-32. PubMed ID: 2875279
    [Abstract] [Full Text] [Related]

  • 19. Hepatosplenic schistosomiasis presenting as spontaneous hemoperitoneum in a Filipino immigrant.
    Okamoto K, Brown JD.
    Am J Med Sci; 2013 Oct 06; 346(4):334-7. PubMed ID: 23588267
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.